Brett Jorgensen
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Glycosylation and Glycoproteins Research, Biosimilars and Bioanalytical Methods, HER2/EGFR in Cancer Research
Most-Cited Works
- → Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment(2010)843 cited
- → Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer(2015)191 cited
- → Regulation of UDP Glucuronosyltransferase Genes(2003)126 cited
- → Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies(2019)100 cited
- → Humanization and characterization of the anti-HLA-DR antibody 1D10(2001)58 cited
- → Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis(2008)46 cited
- → Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies(2019)40 cited
- → Crystal Structure of Human BCMA in complex with UniAb(TM) VH(2019)37 cited
- → TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL(2021)35 cited
- → Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activityin vitroand in human tumor xenografts(2008)34 cited